A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults

NCT04148118 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Anthrax

Interventions

BIOLOGICAL: BW-1010: 50 µg - sprayer - IN
BIOLOGICAL: BW-1010: 50 µg - pipette - IN
BIOLOGICAL: BW-1010: 100 µg - sprayer - IN
BIOLOGICAL: BW-1010: 100 µg - pipette - IN
BIOLOGICAL: Saline (Placebo) - sprayer - IN
BIOLOGICAL: Saline (Placebo) - pipette - IN
BIOLOGICAL: BioThrax (positive control) - SC

Sponsor

BlueWillow Biologics

Collaborators

[object Object]